Filing Flows › Teladoc Health (TDOC) › Q1 2025
Teladoc Health (TDOC) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 1, 2025
Teladoc Health (TDOC) reported revenue of $629M for the first quarter 2025 (Q1 2025), -3% from a year earlier and -2% from the quarter before. Operating margin was -19.2%, net loss $93.0M (14.8% of revenue).
Teladoc Health, Q1 2025: revenue $629M (-3% year over year), operating margin -19.2%, net loss $93.0M, operating cash flow $15.9M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $629M | -2% | -3% |
| Operating profit | −$121M | — | — |
| Net earnings | −$93.0M | — | — |
| Operating cash flow | $15.9M | -81% | +78% |
| Free cash flow | $13.2M | -83% | +70% |
What changed
Revenue was $629.4M in Q1 2025, down 3% year over year and down 2% from the previous quarter. Access Fees was the largest line at 84% of revenue. Access Fees lost $31.4M year over year (down 6%), 188% of the total change.
Operating costs exceeded revenue by $120.6M, an operating margin of -19.2%. Total costs grew 2% against a revenue fall of 3%. The fastest-growing cost line was Other operating costs (+25%). The quarter ended with a net loss of $93.0M, wider than the previous quarter's $48.4M loss.
Operating cash flow was $15.9M (up 78% year over year). Non-cash charges added back $25.2M of share-based compensation. Working capital and other items added $83.8M. Capital expenditures of $2.7M left free cash flow of $13.2M.
Questions
What was Teladoc Health's revenue in the first quarter 2025?
Teladoc Health (TDOC) reported revenue of $629M for the first quarter 2025 (Q1 2025), -3% from a year earlier and -2% from the quarter before.
Was Teladoc Health profitable in the first quarter 2025?
Operating loss was $121M (-19.2% of revenue) and net loss $93.0M.
Source: Teladoc Health 10-Q on SEC EDGAR.